258 related articles for article (PubMed ID: 29581003)
21. Solution structure of the biologically relevant G-quadruplex element in the human c-MYC promoter. Implications for G-quadruplex stabilization.
Ambrus A; Chen D; Dai J; Jones RA; Yang D
Biochemistry; 2005 Feb; 44(6):2048-58. PubMed ID: 15697230
[TBL] [Abstract][Full Text] [Related]
22. Benzothiazole hydrazones of furylbenzamides preferentially stabilize c-MYC and c-KIT1 promoter G-quadruplex DNAs.
Pany SP; Bommisetti P; Diveshkumar KV; Pradeepkumar PI
Org Biomol Chem; 2016 Jun; 14(24):5779-93. PubMed ID: 27021281
[TBL] [Abstract][Full Text] [Related]
23. Relative stability of G-quadruplex structures: Interactions between the human Bcl2 promoter region and derivatives of carbazole and diphenylamine.
Sheu SY; Huang CH; Zhou JK; Yang DY
Biopolymers; 2014 Oct; 101(10):1038-50. PubMed ID: 24723333
[TBL] [Abstract][Full Text] [Related]
24. Investigating actinomycin D binding to G-quadruplex, i-motif and double-stranded DNA in 27-nt segment of c-MYC gene promoter.
Niknezhad Z; Hassani L; Norouzi D
Mater Sci Eng C Mater Biol Appl; 2016 Jan; 58():1188-93. PubMed ID: 26478420
[TBL] [Abstract][Full Text] [Related]
25. Discovery of a New Four-Leaf Clover-Like Ligand as a Potent c-MYC Transcription Inhibitor Specifically Targeting the Promoter G-Quadruplex.
Hu MH; Wang YQ; Yu ZY; Hu LN; Ou TM; Chen SB; Huang ZS; Tan JH
J Med Chem; 2018 Mar; 61(6):2447-2459. PubMed ID: 29474069
[TBL] [Abstract][Full Text] [Related]
26. A cyclometallated iridium(III) complex as a c-myc G-quadruplex stabilizer and down-regulator of c-myc oncogene expression.
Yang H; Ma VP; Chan DS; He HZ; Leung CH; Ma DL
Curr Med Chem; 2013; 20(4):576-82. PubMed ID: 23116145
[TBL] [Abstract][Full Text] [Related]
27. Insights from Binding on Quadruplex Selective Carbazole Ligands.
Müller D; Saha P; Panda D; Dash J; Schwalbe H
Chemistry; 2021 Sep; 27(50):12726-12736. PubMed ID: 34138492
[TBL] [Abstract][Full Text] [Related]
28. Quinazoline derivative QPB-15e stabilizes the c-myc promoter G-quadruplex and inhibits tumor growth in vivo.
Li Z; Liu C; Huang C; Meng X; Zhang L; He J; Li J
Oncotarget; 2016 Jun; 7(23):34266-76. PubMed ID: 27144522
[TBL] [Abstract][Full Text] [Related]
29. Structure-based optimization of FDA-approved drug methylene blue as a c-myc G-quadruplex DNA stabilizer.
Chan DS; Yang H; Kwan MH; Cheng Z; Lee P; Bai LP; Jiang ZH; Wong CY; Fong WF; Leung CH; Ma DL
Biochimie; 2011 Jun; 93(6):1055-64. PubMed ID: 21377506
[TBL] [Abstract][Full Text] [Related]
30. Stabilization of G-quadruplex DNA with platinum(II) Schiff base complexes: luminescent probe and down-regulation of c-myc oncogene expression.
Wu P; Ma DL; Leung CH; Yan SC; Zhu N; Abagyan R; Che CM
Chemistry; 2009 Dec; 15(47):13008-21. PubMed ID: 19876976
[TBL] [Abstract][Full Text] [Related]
31. Insight Derived from Molecular Dynamics Simulation into the Selectivity Mechanism Targeting
Wang Z; Li G; Tian Z; Lou X; Huang Y; Wang L; Li J; Hou T; Liu JP
J Phys Chem B; 2020 Nov; 124(44):9773-9784. PubMed ID: 33089692
[TBL] [Abstract][Full Text] [Related]
32. Structure-based design of flavone derivatives as c-myc oncogene down-regulators.
Yang H; Zhong HJ; Leung KH; Chan DS; Ma VP; Fu WC; Nanjunda R; Wilson WD; Ma DL; Leung CH
Eur J Pharm Sci; 2013 Jan; 48(1-2):130-41. PubMed ID: 23127826
[TBL] [Abstract][Full Text] [Related]
33. Molecular recognition in naphthoquinone derivatives - G-quadruplex complexes by NMR.
Riva B; Ferreira R; Musso L; Artali R; Scaglioni L; Mazzini S
Biochim Biophys Acta; 2015 Apr; 1850(4):673-80. PubMed ID: 25497213
[TBL] [Abstract][Full Text] [Related]
34. In silico identification of novel ligands for G-quadruplex in the c-MYC promoter.
Kang HJ; Park HJ
J Comput Aided Mol Des; 2015 Apr; 29(4):339-48. PubMed ID: 25527072
[TBL] [Abstract][Full Text] [Related]
35. Arene Ru(II) Complexes with Difluorinated Ligands Act as Potential Inducers of S-Phase Arrest via the Stabilization of
Zeng L; Yuan C; Shu J; Qian J; Wu Q; Chen Y; Wu R; Ouyang X; Li Y; Mei W
Molecules; 2022 Mar; 27(6):. PubMed ID: 35335261
[TBL] [Abstract][Full Text] [Related]
36. Wild-type p53 binds to MYC promoter G-quadruplex.
Petr M; Helma R; Polášková A; Krejčí A; Dvořáková Z; Kejnovská I; Navrátilová L; Adámik M; Vorlíčková M; Brázdová M
Biosci Rep; 2016 Oct; 36(5):. PubMed ID: 27634752
[TBL] [Abstract][Full Text] [Related]
37. Structural insight for the recognition of G-quadruplex structure at human c-myc promoter sequence by flavonoid Quercetin.
Tawani A; Mishra SK; Kumar A
Sci Rep; 2017 Jun; 7(1):3600. PubMed ID: 28620169
[TBL] [Abstract][Full Text] [Related]
38. Carbazole-based fluorescent probes for G-quadruplex DNA targeting with superior selectivity and low cytotoxicity.
Yu QQ; Wang MQ
Bioorg Med Chem; 2020 Sep; 28(17):115641. PubMed ID: 32773092
[TBL] [Abstract][Full Text] [Related]
39. The role of positive charges on G-quadruplex binding small molecules: learning from bisaryldiketene derivatives.
Chen SB; Shi QX; Peng D; Huang SY; Ou TM; Li D; Tan JH; Gu LQ; Huang ZS
Biochim Biophys Acta; 2013 Nov; 1830(11):5006-13. PubMed ID: 23880070
[TBL] [Abstract][Full Text] [Related]
40. 12-N-Methylated 5,6-dihydrobenzo[c]acridine derivatives: a new class of highly selective ligands for c-myc G-quadruplex DNA.
Liao SR; Zhou CX; Wu WB; Ou TM; Tan JH; Li D; Gu LQ; Huang ZS
Eur J Med Chem; 2012 Jul; 53():52-63. PubMed ID: 22513122
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
